← Eichor
Condition: Vulvar And Vaginal Cancer Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Vulvar And Vaginal Cancer

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Image-Guided Gynecologic Brachytherapy
NA · 1 location(s) · Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins · NCT02993900Data Collection Study of Pediatric and Adolescent Gynecology Conditions
Phase N/A · 1 location(s) · Eunice Kennedy Shriver National Institute of Child Health an · NCT04717349At-Home Cancer Directed Therapy Versus in Clinic for the Treatment of Patients With Advanced Cancer
Phase 2 · 2 location(s) · Mayo Clinic · NCT05969860A Study Evaluating the Safety, Efficacy, and Pharmacokinetics (PK) of EVOLVE104 in Participants With Advanced Urothelial
Phase 1 · 12 location(s) · EvolveImmune United, Inc · NCT07217171Evaluate the Efficacy, Immunogenicity and Safety of 9-valent HPV Recombinant Vaccine in Chinese Healthy Females
Phase 3 · 1 location(s) · Shanghai Bovax Biotechnology Co., Ltd. · NCT04422366DESTINY-PANTUMOUR04
Phase N/A · 18 location(s) · AstraZeneca · NCT07124000Specimen and Data Study for Ovarian Cancer Early Detection and Prevention
Phase N/A · 1 location(s) · Northwestern University · NCT00005095A Single-arm, Multicenter Clinical Study of Becotatug Vedotin Combined With Zimberelimab in the Treatment of Recurrent a
Phase 2 · 1 location(s) · Union Hospital, Tongji Medical College, Huazhong University · NCT074246643D Printed Custom Applicators for HDR BT (DISCO)
NA · 1 location(s) · Royal North Shore Hospital · NCT06432478A Three-arm Randomized Phase II Study of Dostarlimab Alone or With Bevacizumab Versus Nonplatinum Chemotherapy in Recurr
Phase 2 · 27 location(s) · Yonsei University · NCT06023862Agnostic Therapy in Rare Solid Tumors
Phase 2 · 8 location(s) · Instituto do Cancer do Estado de São Paulo · NCT06638931Retrospective Study of Brachytherapy
Phase N/A · 1 location(s) · Zhejiang Cancer Hospital · NCT05242861Using Reiki Therapy to Improve Symptoms Associated With Brachytherapy in Patients With Gynecological Malignancies
Phase 2 · 1 location(s) · University of Utah · NCT05979610Vaginal DHEA to Improve Vaginal Health After Radiation for Women With Gynecologic, Anal or Rectal Cancer
Phase 2 · 1 location(s) · Ohio State University Comprehensive Cancer Center · NCT07407647HRYZ-T101 Injection for HPV18 Positive Solid Tumor
Phase 1 · 1 location(s) · HRYZ Biotech Co. · NCT05952947ASk Questions in GYnecologic Oncology (ASQ-GYO)
NA · 1 location(s) · Ira Winer · NCT06339827A Phase II, Single-arm, Multicenter, Prospective Study of Cardunolizumab in Recurrent or Metastatic Vulvar and Vaginal C
Phase 2 · 1 location(s) · Zhejiang Cancer Hospital · NCT06292689E7 TCR-T Cell Immunotherapy for Human Papillomavirus (HPV) Associated Cancers
Phase 2 · 3 location(s) · Christian Hinrichs · NCT05686226Physical Activity Intervention Among Older Women With Gynecologic Cancers (Fit4Treatment)
NA · 1 location(s) · Northwestern University · NCT05743517NYSCF Scientific Discovery Biobank
Phase N/A · 1 location(s) · New York Stem Cell Foundation Research Institute · NCT06203106HPV Vaccine, Imiquimod, and Metformin Combination Trial
Phase 2 · 2 location(s) · Baylor College of Medicine · NCT06686043Belzutifan in Recurrent Clear Cell Carcinoma of Gynecologic Origin
Phase 2 · 2 location(s) · Dana-Farber Cancer Institute · NCT06677190E7 T-cell Receptor (TCR) -T Cell Induction Therapy for Locoregionally Advanced HPV-associated Cancers
Phase 1/Phase 2 · 2 location(s) · Christian Hinrichs · NCT05639972SCG142 TCR-T Cells for Human Papillomavirus-Associated Carcinomas
Phase 1 · 1 location(s) · The Affiliated Hospital of Qingdao University · NCT06544720Reirradiation and Total Ablative Strategies for Recurrent Gynecologic Cancer
Phase N/A · 1 location(s) · Affidea Nu-med Center of Oncological DIagnostics and Therapy · NCT07667192
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.